Small-Cap Momentum Watch: Upcoming Catalysts for October 26-30
10/25/20267 min read
From operational updates to conference participation, we've highlighted the small-cap events that could drive attention this week.
--
Companies with Material Events This Week
AVXL - Will attend the NORD Rare Diseases and Orphan Products Breakthrough Summit, taking place October 25-27, 2026, in Washington, D.C. The event brings together rare disease advocates, researchers, biotechnology companies, and industry leaders to discuss advances in orphan drug development, regulatory pathways, patient access, and emerging treatments for rare diseases.
NTRP - Director of Corporate Development Richard Marshall will present at Planet MicroCap Toronto 2026, taking place October 27-29 at Arcadian Court & Loft in Toronto, Canada. The company's presentation is scheduled for October 28 from 11:00-11:30 a.m. ET and will highlight its progress integrating global travel media, consumer bookings, and technology solutions for travel advisors. Management will also participate in one-on-one investor meetings.
EDIT - Will present two posters at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, October 27-30, 2026, in Hamburg, Germany. Both presentations are scheduled for October 28 from 1:30-3:30 p.m. CET and will highlight targeted lipid nanoparticle (LNP) delivery enabling in vivo CAR-T cell generation and therapeutically relevant B-cell depletion, along with development of a configurable, GMP-ready manufacturing platform for targeted LNP therapeutics.
HOVR - Will participate in the Canadian Aerospace Summit 2026, October 27-28, in Ottawa, Ontario, and Planet MicroCap Toronto 2026, October 27-29. Management will be available for investor and industry discussions, providing opportunities to highlight the company's aerospace technology development and business initiatives.
LAES - CEO Carlos Moreira will deliver a keynote presentation at IQT Quantum + AI 2026, October 25-27, in New York City. The October 27 keynote at 9:10 a.m. ET, titled "Securing the Quantum AI Era: From Silicon to Space," will highlight the company's U.S. quantum strategy, semiconductor collaborations, investments in quantum technologies, post-quantum security chips, and space-based quantum infrastructure. Moreira will also participate in a senior executive panel at 3:15 p.m. ET.
XHLD - Chairman and CEO Virgilio Torres will deliver a live corporate presentation through the Skyline Signature Series on October 27, 2026, at 12:00 p.m. ET, providing an opportunity to discuss the company's TEN digital experience platform and corporate developments.
BRNX - Chief Business Officer Gilad Walker of Brenmiller Europe will deliver a keynote presentation at the European C&I Energy Storage and Management Summit 2026, October 27-28, in Frankfurt, Germany. The presentation, titled "Electricity Meets Heat," will focus on integrating renewable energy, battery energy storage systems, and thermal energy storage into commercial and industrial energy platforms, highlighting opportunities for the company's European joint venture.
CVM - Chief Scientific Officer Dr. Eyal Talor will deliver a keynote presentation at the 6th World Congress on Otology, Rhinology and Laryngology, October 26-27, 2026, in Rome, Italy. The presentation will highlight findings from the company's Phase 3 Multikine immunotherapy study in oral squamous cell carcinoma, including previously unpresented analyses examining tumor biomarkers associated with overall survival benefit.
CODX - Will participate in the Utah Mosquito Abatement Association Conference, October 26-28, 2026, focused on mosquito surveillance, vector control, and emerging technologies for monitoring mosquito-borne diseases.
PAPL - Expects its common shares to begin trading on the NYSE American under the new ticker symbol PTIV on or about October 26, 2026, replacing PAPL. The planned ticker change accompanies the launch of its Pentiv mortgage intelligence platform, designed to commercialize software, data, and workflow solutions for independent mortgage brokerages. The proposed corporate name change to Pentiv Inc. remains subject to shareholder approval.
RPID - Will sponsor the PDA Pharmaceutical Microbiology Conference 2026, October 26-28, in Washington, D.C. The event brings together pharmaceutical microbiology professionals, regulatory experts, and quality-control leaders to discuss emerging technologies, evolving regulatory standards, and advancements in pharmaceutical manufacturing and microbiological testing.
VSME - Expects its Nasdaq ticker symbol to change from VSME to FCDH at market open on October 26, 2026, following shareholder approval of its corporate name change to Forcendra Holding Limited. Approximately 94% of votes cast supported each proposal. The company's Class A ordinary shares will continue trading on the Nasdaq Capital Market, with the CUSIP number remaining unchanged.
BOF - Will deliver an investor presentation at Planet MicroCap Toronto 2026 on October 28 at 9:00 a.m. ET, providing an opportunity for management to discuss corporate developments and engage with the microcap investment community.
IMRN - CEO Steven Lydeamore will present virtually at the Emerging Growth Conference on October 28, 2026, from 4:25-4:55 p.m. ET, providing investors with an opportunity to hear updates on the company's business and development activities.
MSGY - Will change its Nasdaq ticker symbol from MSGY to FFTT, effective at the opening of trading on October 28, 2026. The ticker change will not require any action from existing shareholders, and the company's CUSIP number will remain unchanged.
PYPD - Will host a virtual Investor Day on October 28, 2026, at 11:30 a.m. ET to introduce its "PolyPid 2030" long-term growth and pipeline strategy. Management will provide an update on D-PLEX100, its lead candidate for preventing colorectal surgical site infections, currently under FDA Priority Review with a November 28, 2026 PDUFA goal date, and introduce PD01B, a new Kynatrix-based product candidate being developed for diabetic foot infections.
CHRS - Will release interim clinical data from its tagmokitug development program on October 28, 2026, evaluating the cytolytic CCR8 antibody in combination with toripalimab across multiple solid tumors. Management will host a webcast from 4:30-6:00 p.m. ET featuring key opinion leaders who will discuss the clinical findings and their implications for the program.
PRSO - CEO Ron Glibbery will present at Planet MicroCap Toronto 2026 on October 28 at 8:00 a.m. ET at Arcadian Loft in Toronto, Canada. Management will also conduct investor meetings October 28-29, with a live and archived webcast of the corporate presentation available to investors.
NOMA - Will host an investor webinar on October 28, 2026, at 11:00 a.m. ET featuring company executives and Fox Soccer Academy co-founders Christian Fuchs and Raluca Gold-Fuchs. The discussion will focus on Nomadar's definitive agreement to acquire a majority interest in Fox Soccer Academy, the proposed transaction, and future business development plans.
USIO - Chairman and CEO Louis Hoch will present at Planet MicroCap Toronto 2026 on October 28 at 12:30 p.m. ET, providing investors with an opportunity to review the company's business developments and growth strategy.
FEMY - Will participate in the American Society for Reproductive Medicine (ASRM) 2026 Scientific Congress & Expo, October 24-28, in Baltimore, Maryland. The company will exhibit at Booth 513, engaging reproductive medicine specialists, clinicians, and industry professionals regarding its women's health and fertility technologies.
AREC - Will participate in the E-Waste World Expo, October 28-29, 2026, in Atlanta, Georgia. The event focuses on electronics recycling, resource recovery, sustainable materials management, and technologies supporting the recovery of valuable materials from electronic waste.
SNAL - Is scheduled to launch its new video game Dead Party on Steam on October 29, 2026. The release represents a new addition to the company's gaming portfolio and follows ongoing marketing initiatives supporting its broader lineup of interactive entertainment titles.
ANTX - Will present its planned Phase 2 clinical trial design for epetraborole in patients with phlebotomy-dependent polycythemia vera at the 18th International Congress on Myeloproliferative Neoplasms on October 29, 2026, from 5:45-7:15 p.m. ET in Brooklyn, New York. The poster presentation will outline the company's proposed Phase 2 development strategy for epetraborole.
XFOR - Will host a virtual Investor Day on October 29, 2026, from 10:00 a.m.-12:00 p.m. ET. Management and key opinion leaders will review the company's Phase 3 4WARD clinical development program and outline its planned Phase 2 study evaluating mavorixafor in combination with G-CSF, including the clinical strategy and upcoming development milestones.
ZBAO - Zhibao Technology's acquisition of NEXSYS TECH remains expected to close around October 28, 2026, subject to due diligence, regulatory approvals, and other customary closing conditions. ZBAO would acquire 100% of NEXSYS for $1 upfront, with up to $7.5M of additional Class A share consideration tied to future profit targets.
TNMG - TNL Mediagene's sale of its Japanese business to MI Company remains expected to close on or before October 30, 2026, subject to customary closing conditions, with an outside date of November 30.
INO - FDA review of INO-3107 for recurrent respiratory papillomatosis remains ongoing with an unchanged October 30, 2026 PDUFA target action date. INOVIO has completed its late-cycle review meeting and scheduled pre-licensure inspections ahead of the FDA decision.
CUPR - Cuprina's acquisitions of East Coast Podiatry Centre and Orchard Clinic Management remain expected to complete on or before November 1, 2026, subject to customary closing conditions. The approximately S$4.0M transaction would add seven Singapore clinics and is being funded with a mix of cash and CUPR shares.
FNGR - FingerMotion's acquisition of 100% of Newbit Technology remains expected to close on or before October 29, 2026, subject to customary closing conditions. The $2.3M cash transaction would secure the lease, permits, pipeline and gas infrastructure, environmental approval, Alberta Utilities Commission registration, and fixed civil works associated with the 9.9 MW Brooks Campus #1 site.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.